Class Action Lawsuit vs Bausch Health Companies Inc. (BHC)

Allegations

The complaint alleges that defendants made false and/or misleading statements about the Company's spinoff of the Bausch + Lomb Corporation ("B+L"), including the benefits it would provide for Bausch shareholders and the effects it would have on Bausch post-spinoff. The complaint also alleges that the spinoff was done not to benefit shareholders but instead to undermine plaintiff lawsuits stemming from securities laws violations in 2016. Defendants' statements about the B+L spinoff have caused significant damages for Bausch investors. On August 6, 2020, when the spinoff was announced, Bausch's stock closed at $20.13 per share. The stock traded as high as $34.38 per share before falling to its current trading prices of under $10 per share.

Eligibility

In order to be included in the lawsuit, you must have incurred a loss on shares of Bausch, either: A) purchased or acquired during the class period listed above, if applicable; or B) pursuant to the Initial Public Offering (IPO) of Bausch, if applicable.

Lead Plaintiff Deadline

If you suffered a loss in Bausch during the relevant time frame, or pursuant to Bausch's IPO if listed above, you have until September 25, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.